Results 121 to 130 of about 9,317,521 (244)

TREATMENT OF PEYRONIE'S DISEASE

Медицина в Кузбассе, 2017
Here we present a review of global data on known methods of treatment of Peyronie's disease. A comparative analysis of surgical techniques is performed.
Павел Сергеевич Кызласов, Алексей Георгиевич Мартов, Евгений Владимирович Помешкин, Владислав Маратович Трояков, Федор Петрович Капсаргин   +4 more
doaj  

Changes in the Effects of Peyronie's Disease After Treatment With Collagenase Clostridium histolyticum: Male Patients and Their Female Partners

Sexual Medicine, 2017
Introduction: Collagenase Clostridium histolyticum (CCH) intralesional injection was efficacious for the management of Peyronie's disease (PD) in the double-blinded, randomized, placebo-controlled Investigation for Maximal Peyronie's Reduction Efficacy ...
Irwin Goldstein, MD, L. Dean Knoll, MD, Larry I. Lipshultz, MD, Ted Smith, PhD, Gregory J. Kaufman, MD, Chris G. McMahon, MBBS   +5 more
doaj   +1 more source

Surgical management of peyronie’s disease with co-existent erectile dysfunction [PDF]

, 2019
Introduction: Surgical intervention in Peyronie’s disease (PD) should ideally be delayed until the resolution of acute inflammatory phase. Aim: The objective of this review was to highlight the results of penile prosthesis to correct refractory ...
Carballido, Joaquín, Fernández-Pascual, Esaú, Krishnappa, Pramod, Lledo-García, Enrique, Martínez-Salamanca, Juan Ignacio, Moncada, Ignacio   +5 more
core   +1 more source

Peyronie’s Disease: Still a Surgical Disease

Advances in Urology, 2012
Peyronie’s Disease (PD) remains a challenging and clinically significant morbid condition. Since its first description by François Gigot de la Peyronie, much of the treatment for PD remains nonstandardized. PD is characterized by the formation of fibrous
Daniel Martinez, Cesar E. Ercole, Tariq S. Hakky, Andrew Kramer, Rafael Carrion   +4 more
doaj   +1 more source

Validation of the Italian Version of the Peyronie’s Disease Questionnaire (PDQ) [PDF]

, 2023
Massimo Di Grazia, Luca Ongaro, Michele Rizzo, Andrea Cocci, Paolo Verze, Alessandro Zucchi, Tommaso Cai, Leonardo Salamè, Giulio Garaffa, Carlo Trombetta, Giovanni Liguori, Fabio Traunero   +11 more
openalex   +1 more source

Hydroelectrophoresis for Transdermal Administration of Verapamil or of Hyaluronic Acid in Peyronie's Disease: A Prospective, Open Label, Multicenter Study [PDF]

, 2018
Aim & Objective: To assess the efficacy of a new electromotive system for the transcutaneous delivery of verapamil or of hyaluronic acid to improve the symptoms of Peyronie' s disease (PD) in patients with a curvature deformity of < 30° at the ...
Cavallini, Giorgio, Maretti, Carlo
core   +2 more sources

(375) Can Tamoxifen and a PDE5 inhibitor slow the progression of Peyronie’s Disease? [PDF]

, 2023
Matthew Megson, C Merrett, Selim Cellek, David Ralph   +3 more
openalex   +1 more source

Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases

International journal of impotence research, 2022
N. Schifano, P. Capogrosso, L. Boeri, G. Fallara, S. Chiappini, M. Rewhorn, O. Cakir, H. Harvey, F. Castiglione, H. Alnajjar, A. Muneer, F. Dehò, F. Schifano, F. Montorsi, A. Salonia   +14 more
semanticscholar   +1 more source

Simvastatin and the Rho‐kinase inhibitor Y‐27632 prevent myofibroblast transformation in Peyronie's disease‐derived fibroblasts via inhibition of YAP/TAZ nuclear translocation

BJU International, 2019
To uncover the anti‐myofibroblast (MFB) properties of Rho‐kinase inhibitor (compound Y‐27632) and simvastatin in an in vitro model of Peyronie's disease (PD), a sexually debilitating disease caused by an irreversible fibrotic plaque in the penile tunica ...
U. Milenkovic, M. Ilg, C. Zuccato, Yasaman Ramazani, D. de Ridder, M. Albersen   +5 more
semanticscholar   +1 more source

Role of interleukin-6 and pentraxin 3 as an early marker in Peyronie’s disease

Kaohsiung Journal of Medical Sciences, 2017
Inflammation is mechanistically involved in the development of Peyronie’s disease (PD). The aim of this study is to assess the relevance of serum pentraxin 3 (PTX3) and interleukin-6 (IL-6) concentrations in PD.
Arda Atar, Alev Kural, Gurkan Yenice, Ilker Comez, Volkan Tugcu   +4 more
doaj   +1 more source